Deborah Dunsire, M.D.
Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Deborah Dunsire, M.D.
Deborah Dunsire, M.D. is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE). Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 21, 2024 that Deborah Dunsire, M.D. was appointed Class II Director, effective June 18, 2024.
“At the Annual Meeting, the Company's stockholders elected the Class II director nominees below to the Company's Board of Directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.